爱游戏·(中国)官方网站

Welcome to Anhui Poly Pharm. Co., Ltd.
language
中文 EN
GO
Hot news
News
News information
Learn more

爱游戏·(中国)官方网站Anhui Poly’s Gadoterate Meglumine API approved for marketing, with annual production capacity of up to 20 tons!

Anhui Poly Pharm. Co., Ltd. (hereinafter referred to as “Anhui Poly”), a subsidiary of Hainan Poly Pharm. Co., Ltd. (hereinafter referred to as “Poly Pharm.”), recently received the approval notification of marketing application for chemical API Gadoterate Meglumine issued by NMPA (Notification No. 2024YS00506).

View details

爱游戏·(中国)官方网站Anhui Poly anti-tumor API cyclophosphamide has been approved for marketing, with an annual production capacity of up to 10 tons!

Anhui Poly Pharm. Co., Ltd. (hereinafter referred to as "Anhui Poly"), a subsidiary of Hainan Poly Pharm. Co., Ltd. (hereinafter referred to as "Poly Pharm."), has recently received the Notice of Approval about application for marketing of cyclophosphamide chemical raw material issued by the National Medicinal Product Administration (hereinafter referred to as "NMPA") (Notice number: 2024YS00429).

View details
about Us
About Anhui Poly
Anhui Poly Pharmaceutical Co., Ltd., as a wholly-owned subsidiary of Hainan Puli Pharmaceutical, was established in 2018 and is an important part of Puli Pharmaceutical's expansion and layout towards raw materials. Anhui Puli Pharmaceutical Co., Ltd. has a large scale, with the first phase covering an area of 186.5 acres and an investment of 1 billion yuan. The company strictly adheres to domestic standards in design, installation, and construction of auxiliary facilities...
Learn more

  • Established in

  • Gadolinium contrast agent workshop and anti-tumor workshop have passed FDA inspection in the United States

  • Production approval and filing number of active pharmaceutical ingredients

  • Production approval and filing number for medicinal excipients

  • Effective Innovation Invention Patent

products
Our product

Adhere to the positioning of differentiation and internationalization, establish a complete quality system in accordance with international GMP certification standards, follow standardized quality management systems and process standards, and strictly control drug quality.

Learn more
    • CDMO
    CDMO services
    Three raw material production workshops that meet the GMP standards of China, Europe and America, seven production lines, and a total of 150 30L~5000L reaction kettles. In addition to the reaction kettles, there are also more than 200 other main equipment (drying equipment, centrifuge equipment, vacuum equipment, purification equipment, etc.), and can produce more than 10 to 20 varieties. The maximum production capacity of a single production line can reach more than 100 tons/year. Covering products such as ordinary chemical raw materials, contrast agents, and anti-tumor agents..
    Learn more
    Bulk drug sales
    Dr. Nie18857699687
    Ms. Xue13616562513
    Mr. Li18720526102
    Contact number0571-89385087 / 0571-89385057
    CDMO
    Dr. Nie
    18857699687
    nielcvhjdeng@hnpoly.com
    Ms. Xue
    13616562513
    ff@hnugry.com
    Mr. Li
    18720526102
    liruowei@hnpoly.com
    innovate
    Scientific research innovation
    The company firmly establishes a quality awareness and brand awareness of "ensuring drug quality and building a century old pharmaceutical enterprise", and has established a quality assurance system that is in line with international quality supervision concepts such as FDA, ICH, and EDQM. The internal control quality standards of the products are all higher than the quality requirements of national legal standards
    More
    No.58 Xiahong Road, High-Tech Industrial Development Zone Anqing, Anhui, China 246000
    Copyright ? 2024 Anhui Poly Pharm. Co., Ltd. All Rights Reserved . 皖ICP备2024049420号-1